PainChek Limited Share Price

Equities

PCK

AU000000PCK6

Software

Market Closed - Australian S.E. 07:10:05 29/04/2024 BST 5-day change 1st Jan Change
0.031 AUD 0.00% Intraday chart for PainChek Limited +3.33% -16.22%

Financials

Sales 2022 994K 653K 51.96M Sales 2023 1.96M 1.28M 102M Capitalization 32.45M 21.31M 1.7B
Net income 2022 -5M -3.28M -261M Net income 2023 -7M -4.6M -366M EV / Sales 2022 28.7 x
Net cash position 2022 6.14M 4.03M 321M Net cash position 2023 2.51M 1.65M 131M EV / Sales 2023 15.3 x
P/E ratio 2022
-5.52 x
P/E ratio 2023
-4.26 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 66.56%
More Fundamentals * Assessed data
Dynamic Chart
1 week+3.33%
Current month-3.12%
1 month-3.12%
3 months-11.43%
6 months-31.11%
Current year-16.22%
More quotes
1 week
0.03
Extreme 0.029
0.03
1 month
0.03
Extreme 0.028
0.03
Current year
0.03
Extreme 0.026
0.04
1 year
0.02
Extreme 0.024
0.07
3 years
0.02
Extreme 0.024
0.07
5 years
0.02
Extreme 0.024
0.37
10 years
0.02
Extreme 0.024
0.37
More quotes
Managers TitleAgeSince
Chief Executive Officer - 29/09/16
Director of Finance/CFO - 21/03/21
Chief Operating Officer - 30/11/20
Members of the board TitleAgeSince
Chairman 65 29/09/16
Director/Board Member 79 29/09/16
Director/Board Member - 29/09/14
More insiders
Date Price Change Volume
29/04/24 0.031 0.00% 463,562
26/04/24 0.031 +3.33% 1,271,784
24/04/24 0.03 +3.45% 868,164
23/04/24 0.029 -3.33% 2,322,624

Delayed Quote Australian S.E., April 29, 2024 at 07:10 am

More quotes
PainChek Ltd is an Australia-based company, which develops pain assessment technologies. The Company’s principal activities are development and commercialization of mobile medical device applications that provide pain assessment for individuals that are unable to communicate with their carers. The Company’s PainChek Universal is a complete point-of-care solution that combines the existing PainChek Application with the numerical rating scale (NRS). PainChek Application uses artificial intelligence and facial recognition to detect pain in those who cannot self-report. This gives a voice to those who cannot verbalize pain, whilst also driving objectivity and consistency in all assessments. For those who can self-report, PainChek Universal also includes access to the NRS, a standard used to document pain levels amongst these individuals. PainChek Universal also supports pain assessment using both tools at the point of care, for those people whose ability to communicate fluctuates.
More about the company

Annual profits - Rate of surprise